Health Business

Dr. Reddy’s Laboratories announces the commercialization of Vozet in India

Dr. Reddy’s Laboratories Ltd announced today the commercilazation of Vozet Tablets in India, indicated for the treatment of allergic Rhinitis and chronic Urticaria.

Dr. Reddy

The Vozet Tablets contain Levocetirizine 5 mg, and are available in a strip size of 10.

The anti-histamine market in India had sales of INR 1038cr MAT for the most recent twelve months ended in March 2017, according to IMS ORG. Dr. Reddy’s will further strengthen its anti-allergy portfolio with the addition of Vozet.

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Most Popular

To Top